avxt vs. interferon
One of my earlier posts may have been the basis for the $20,000 figure used as a "cost per treatment" estimate - so let me expand that a little bit.
Several times, I have seen the estimate of $25,000 used for the Interferon treatment alternative. Interferon has an effectiveness of 22-25% five year survival when used against Stage III Malignant Melanoma. It also has significant side effects like severe nausea and requires a year or so of these teatments (and cocurrent side effects). Given the low (5%) increase in cure rate over surgury alone, some patients may elect to discontinue the treatment early.
M-vax, on the other hand, has almost no side effects other than some vaccination type scars and a bit of temporary discomfort. The 5 year survival rate is significantly higher - 55% and more.
Now ask yourself the question: If I were a Stage III melanoma patient and had a good chance of dying from this stuff, would I rather pay $25,000 for Interferon, get sick for a year, and have a 25% of living OR would I be willing to pay $20,000, get a little sore over 6 weeks and have better than a 55% chance of living?
The answer to me is definitely the latter !!!! It should be a "slam dunk" choice for oncologists who have the information - and should provide a very profitable product for AVAX and its stockholders.
Thumper |
